跳至主要内容
临床试验/NCT04466501
NCT04466501已完成不适用

A Comparative, Controlled Study to Evaluate the Performance of the ACR | LAB Urine Analysis Test System

Healthy.io Ltd.3 个研究点 分布在 1 个国家目标入组 375 人开始时间: 2019年6月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
375
试验地点
3
主要终点
Evaluate the performance agreement of the ACR |LAB compared to the comparator device, tested by professional users.

研究概览

简要总结

The ACR LAB is a prescription-only, nurse- or clinician-conducted in vitro diagnostic (IVD) device. The test is for the qualitative and semi- quantitative detection of Albumin, Creatinine, and the Albumin-to- Creatinine Ratio. The device is composed of a kit and a smartphone application using an image recognition algorithm.

The degree of agreement of the ACR | LAB as compared to the comparator device will be tested. Urine samples will be tested by a separate professional user on each device.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Men and women 18-80 years of age;
  • •Subjects who are healthy or pregnant; or
  • •Subjects diagnosed with a disease that normally represents itself with an abnormal concentration of albumin:
  • •Diabetes Type I/Type II,
  • •Hypertension,
  • •Any kidney disease,
  • •Other relevant conditions.
  • •Subjects with any pathological findings which might be identified by the urine test (according to the physician discretion);
  • •Subject is capable and willing to provide informed consent;
  • •Subject has facility with both hands
  • •Subject is capable and willing to adhere to the study procedures.

排除标准

  • 未提供

研究组 & 干预措施

ACR LAB for Professional User

Experimental

干预措施: ACR LAB (Device)

结局指标

主要结局

Evaluate the performance agreement of the ACR |LAB compared to the comparator device, tested by professional users.

时间窗: 11 months

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验